Health And Medicine

A study of 381 non-Vanderbilt physicians referred to the Vanderbilt Comprehensive Assessment Program has shown that those referred for mental health, substance abuse and improper sexual boundary issues are less likely to receive a fit for duty recommendation than those referred for disruptive behavior. Read More

Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. Read More

When it comes to government funding of basic science training programs for graduate students and postdoctoral fellows, Vanderbilt University Medical Center hit a grand slam this year, officials said. Read More

A new in vitro system will allow investigators to explore how immune system T cells develop specialized functions. Read More

A study of 381 non-Vanderbilt physicians referred to the Vanderbilt Comprehensive Assessment Program (VCAP) in the Department of Psychiatry has shown that those referred for mental health, substance abuse and improper sexual boundary issues are less likely to receive a fit for duty recommendation than those referred for disruptive behavior. Read More

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read More

Alkaline phosphatase enzymes appear to play roles in promoting pregnancy and in protecting the uterus from bacterial infection. Read More

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Read More

Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts. Read More

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read More

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Read More

Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read More

Vanderbilt University researchers have discovered a new critical component in the obesity pathway. Read More

In an effort to understand how neurons develop different “architectures,” Vanderbilt developmental biologists have discovered a genetic switch that controls one type of neuron branching in the nematode worm. Read More

A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care. Read More

A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer. Read More

A partnership with Vanderbilt University and Nashville-based Ingram Barge was formed in order to study sleep deprivation in Ingram’s employees and address the issues of pilot fatigue and public safety on the waterways. Patience Bridges, sleep program coordinator at the Vanderbilt Sleep Center, is quoted. Read More

Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone. Read More

Once upon a time, teenage girls were not clamoring to sport a pair of thick, black, oversized eyeglasses. Read More

The protein SARM appears to protect cells from inflammation-driven death by stabilizing the nuclear laminin scaffold. Read More